Korro Bio, Inc. Earnings Per Share (Diluted)
Korro Bio, Inc. (KRRO) reported Earnings Per Share (Diluted) of -$1.07 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- Korro Bio, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$1.07.
- Korro Bio, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$1.69.
- Korro Bio, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$5.32.
- Korro Bio, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$1.92.
- Korro Bio, Inc. earnings per share, diluted for fiscal 2025 was -$12.48.
- Korro Bio, Inc. earnings per share, diluted for fiscal 2024 was -$9.37.
- Korro Bio, Inc. earnings per share, diluted for fiscal 2023 was -$53.08.
- Korro Bio, Inc. earnings per share, diluted for fiscal 2022 was -$227.42.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.07 10-Q · filed 2026-08-06 | -$2.64 10-Q · filed 2026-08-06 | -$6.88 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$8.88 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2026-03-31 | -$1.69 10-Q · filed 2026-05-07 | -$6.63 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$8.66 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$11.41 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-12-31 | -$5.32 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$7.24 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$9.99 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$12.48 10-K · filed 2026-03-12 | ||
| 2025-09-30 | -$1.92 10-Q · filed 2025-11-12 | -$4.67 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$7.16 10-Q · filed 2025-11-12 | -$9.42 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-06-30 | -$2.74 10-Q · filed 2026-08-06 | -$5.24 10-Q · filed 2026-08-06 | -$7.50 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$9.76 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2025-03-31 | -$2.49 10-Q · filed 2026-05-07 | -$4.76 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$7.01 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$9.44 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||
| 2024-12-31 | -$2.26 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$4.52 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$6.94 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$9.37 10-K · filed 2026-03-12 | ||
| 2024-09-30 | -$2.26 10-Q · filed 2025-11-12 | -$4.68 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$7.11 10-Q · filed 2025-11-12 | -$11.12 derived: net income ÷ weighted average shares · filed 2026-04-16 | ||
| 2024-06-30 | -$2.43 10-Q · filed 2025-08-12 | -$4.87 10-Q · filed 2025-08-12 | -$8.99 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$15.11 derived: net income ÷ weighted average shares · filed 2026-04-16 | ||
| 2024-03-31 | -$2.44 10-Q · filed 2025-05-07 | -$6.76 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$14.01 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$23.40 derived: net income ÷ weighted average shares · filed 2026-04-16 | ||
| 2023-12-31 | -$4.81 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$15.77 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$31.60 derived: net income ÷ weighted average shares · filed 2026-04-16 | -$53.08 10-K · filed 2025-03-18 | ||
| 2023-09-30 | -$65.08 10-Q · filed 2024-11-12 | -$0.31 10-Q · filed 2023-11-02 | -$128.93 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$200.94 10-Q · filed 2024-11-12 | -$1.17 10-Q · filed 2023-11-02 | $1.92 derived: net income ÷ weighted average shares · filed 2024-11-12 |
| 2023-06-30 | -$63.83 10-Q · filed 2024-08-13 | -$135.96 10-Q · filed 2024-08-13 | $0.90 derived: net income ÷ weighted average shares · filed 2024-11-12 | $2.97 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-03-31 | -$72.20 10-Q · filed 2024-05-14 | $0.26 derived: net income ÷ weighted average shares · filed 2024-11-12 | $1.44 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2022-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-03-26 | $0.39 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$227.42 10-K · filed 2024-03-26 | |||
| 2022-09-30 | -$0.55 10-Q · filed 2023-11-02 | -$1.83 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |